Rakesh Kalbate - Krebs Biochemicals Company Officer
| KREBSBIO | 97.79 15.49 18.82% |
Executive
Rakesh Kalbate is Company Officer of Krebs Biochemicals and
| Address | Kothapalli Village, Visakhapatnam, India, 531031 |
| Phone | 91 91 2114 4984 |
| Web | https://krebsbiochem.com |
Krebs Biochemicals Management Efficiency
The company has return on total asset (ROA) of (0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals' Other Current Assets are increasing as compared to previous years. The Krebs Biochemicals' current Total Current Assets is estimated to increase to about 278.7 M, while Total Assets are projected to decrease to under 1.3 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rachna Mehra | Arvind Limited | N/A | |
| Sujata Jain | GACM Technologies Limited | N/A | |
| Ramnik Bhimani | Arvind Limited | N/A | |
| Abhijit Doshi | Heubach Colorants India | N/A | |
| Arpit Maheshwari | Tribhovandas Bhimji Zaveri | N/A | |
| Jim Easow | Heubach Colorants India | N/A | |
| Ashwini Natekar | Heubach Colorants India | N/A | |
| Shirish Upadhyay | Parag Milk Foods | N/A | |
| Xie Dongming | Kingfa Science Technology | N/A | |
| Sareena Kochar | Lemon Tree Hotels | 60 | |
| Liuwei He | Kingfa Science Technology | 49 | |
| Rakesh Sharma | Rico Auto Industries | N/A | |
| Nikhil Sethi | Lemon Tree Hotels | 44 | |
| Sachin Shah | Parag Milk Foods | N/A | |
| Abhishek Kulshrestha | Rico Auto Industries | N/A | |
| Kaushal Shah | Arvind Limited | N/A | |
| Praveen Kalawar | Heubach Colorants India | N/A | |
| Ruchika Gupta | Rico Auto Industries | N/A | |
| Abhishek Bansal | Arvind Limited | N/A | |
| CS CA | Tribhovandas Bhimji Zaveri | N/A | |
| Amee Joshi | Heubach Colorants India | N/A | |
Management Performance
| Return On Asset | -0.0532 |
Krebs Biochemicals and Leadership Team
Elected by the shareholders, the Krebs Biochemicals' board of directors comprises two types of representatives: Krebs Biochemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Krebs. The board's role is to monitor Krebs Biochemicals' management team and ensure that shareholders' interests are well served. Krebs Biochemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Krebs Biochemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rakesh Kalbate, Company Officer | ||
| Aditya Ravi, Head Vizag | ||
| Sudhir Manne, Head Nellore | ||
| Keyur Doshi, Company Officer | ||
| Ritesh Jain, Chief Officer | ||
| Ravi Babu, Chief Officer | ||
| Jitendra Shah, CEO MD | ||
| Pabitra Bhattacharya, MD Director |
Krebs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Krebs Biochemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0532 | ||||
| Profit Margin | (0.37) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 4.06 B | ||||
| Shares Outstanding | 21.56 M | ||||
| Shares Owned By Insiders | 77.55 % | ||||
| Price To Sales | 4.02 X | ||||
| Revenue | 504.21 M | ||||
| Gross Profit | 244.19 M | ||||
| EBITDA | (82.73 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.